Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (1) , S94-S100
Abstract
No abstract availableKeywords
Funding Information
- Center for Cancer Research, National Cancer Institute, Intramural Research Program
This publication has 46 references indexed in Scilit:
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic MalignanciesTransplantation and Cellular Therapy, 2010
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TransplantationTransplantation and Cellular Therapy, 2010
- Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensBlood, 2010
- Introduction to the Reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionTransplantation and Cellular Therapy, 2010
- Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A ReviewTransplantation and Cellular Therapy, 2009
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaBlood, 2009
- Salvage of Donor Graft with Decitabine and Maintenance Post Allogeneic Stem Cell Transplantation in Myelodysplastic/Myeloproliferative Disease: A Case ReportClinical Leukemia, 2009
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006